In a report released today, Gena Wang from Barclays maintained a Hold rating on Crispr Therapeutics AG (CRSP – Research Report), with a price ...

CRISPR Therapeutics AG (CRSP) closed at $39.41 in the latest trading session, marking a -0.76% move from the prior day.

We recently compiled a list of the Cathie Wood’s Stock Portfolio: 2025 Stock Picks. In this article, we are going to take a ...

Barclays analyst Gena Wang raised the firm’s price target on Crispr Therapeutics (CRSP) to $56 from $55 and keeps an Equal Weight rating on the ...

If an investor was to purchase shares of CRSP stock at the current price level of $42.35/share, and then sell-to-open that call contract as a "covered call," they are committing to sell the stock ...

This performance came about at a time when Bitcoin’s price had reached ... of Cathie Wood’s top stock picks for 2025. While we acknowledge the potential of CRSP as an investment, our ...

CRISPR Therapeutics CRSP is expected to report fourth-quarter and full-year 2024 earnings later this month. The Zacks ...

Based on data from MarketBeat.com, the stock currently has an average rating of “Hold” and a consensus target price of $77.59. Shares of CRSP stock opened at $40.61 on Wednesday. The stock’s ...